Insmed Form 144 for 1,396 share stock sale

Insmed Inc. (INSM) reported a planned sale of company stock under Rule 144.

Accepted by SEC EDGAR 01/06/2026 - 04:26 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Insmed Inc. (INSM) reported a planned sale of company stock under Rule 144. A holder intends to sell 1,396 shares of common stock through Merrill Lynch on or about 01/06/2026 on the NASDAQ market, with an aggregate market value of $241,968.68 based on the figures shown. These shares were acquired from the issuer on 01/04/2026 through stock plan activity, with the same date listed as the payment date.

The notice also reports that during the past three months, Michael Smith sold 27,130 common shares on 11/03/2025 for gross proceeds of $4,985,054. The filing lists 213,273,469 common shares outstanding for the issuer, providing context for the size of the planned transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Insmed (INSM) shares are planned to be sold in this Form 144?

The notice covers a planned sale of 1,396 shares of Insmed common stock, to be sold through Merrill Lynch on the NASDAQ exchange.

What is the aggregate market value of the Insmed (INSM) shares in this Form 144?

The 1,396 common shares listed for sale have an aggregate market value of $241,968.68 based on the amounts shown in the filing.

When were the Insmed (INSM) shares to be sold under this Form 144 acquired?

The shares were acquired on 01/04/2026 through stock plan activity from the issuer, with the same date given as the payment date.

When is the approximate sale date for the Insmed (INSM) shares in this Form 144?

The approximate date of sale for the 1,396 Insmed common shares is listed as 01/06/2026, with the shares to be sold on the NASDAQ.

How many Insmed (INSM) shares were sold in the past 3 months by this seller?

During the past three months, 27,130 Insmed common shares were sold on 11/03/2025 for total gross proceeds of $4,985,054.

What is the total number of Insmed (INSM) common shares outstanding referenced in this Form 144?

The filing lists 213,273,469 common shares of Insmed outstanding, which serves as a baseline figure alongside the planned 1,396-share sale.

Which broker and exchange are involved in this Insmed (INSM) Form 144 sale?

The planned sale is to be executed through Merrill Lynch, with the securities identified for trading on the NASDAQ exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001870278
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	INSMED INC
SEC File Number	000-30739
Address of Issuer	700 US Highway 202/206 Bridgewater NEW JERSEY 08807
Phone	9089779900
Name of Person for Whose Account the Securities are To Be Sold	Michael Smith
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1800 K ST NW Suite 800 Washington DC 20006	1396	241968.68	213273469	01/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/04/2026	Stock Plan Activity	Issuer			1396	01/04/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Smith 700 US Highway 202/206 Bridgewater NJ 08807	Common	11/03/2025	27130	4985054

144: Remarks and Signature

Remarks
Date of Notice	01/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Michael Smith
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)